德国友人弗洛尔谈mRNA疫苗，我的国家仍然热衷于中国展开合作。
面对新冠疫情，全世界都在努力。
德国友人——特里夏·弗洛尔在本月27日表示，表示他的国家仍然热衷于在mRNA领域与中国展开合作。
“BioNTech 和德国官方一直对与中国开展 mRNA 专业知识的不同功能方面的合作持开放态度，以便将它们引入中国”
“BioNTech and the German authorities have been open for cooperation with China on vaccines and different functions based mostly on mRNA expertise, for introducing them into the Chinese language market,” Flor stated. “And this provide nonetheless stands.”
国内尚未使用包括 BioNTech 疫苗在内的 mRNA 疫苗。BioNTech和德国官方一直对与中国在基于mRNA技术的疫苗和其他应用方面的合作持开放态度，以将其引入中国市场。这个提议仍然有效。
China has not yet approved mRNA vaccines, including the BioNTech vaccine. BioNTech and the German have been open to cooperation with China on vaccines and other applications based on mRNA technology, for introducing them into the Chinese market. And this offer still stands.
以上节选自南早报道